Derry Roopenian

Title: Derry Roopenian: Innovator in Antibody Therapeutics

Introduction

Derry Roopenian is a notable inventor based in Salsbury Cove, ME (US). He has made significant contributions to the field of antibody therapeutics, holding two patents that focus on innovative treatments for various disorders.

Latest Patents

Roopenian's latest patents include "Humanized affinity matured anti-FcRn antibodies." This patent describes recombinant antibodies and antigen-binding portions that are useful for binding to FcRn and blocking its interaction with human serum albumin. These FcRn-binding proteins have potential applications in treating a variety of disorders, including acute and chronic toxic exposure. Another patent under his name is also titled "Humanized affinity matured anti-FcRn antibodies," which focuses on blocking the binding of FcRn to IgG Fc. This innovation aims to provide therapeutic options for autoimmune disorders.

Career Highlights

Derry Roopenian has established himself as a key figure in the biotechnology sector, particularly through his work at Syntimmune, Inc. His research and inventions have paved the way for advancements in the treatment of complex medical conditions.

Collaborations

Roopenian has collaborated with esteemed colleagues, including Laurence J Blumberg and Richard S Blumberg, contributing to the development of groundbreaking therapeutic solutions.

Conclusion

Derry Roopenian's work in antibody therapeutics exemplifies the impact of innovative thinking in medicine. His patents reflect a commitment to addressing critical health challenges through scientific advancement.